New diagnostic possibilities with B·R·A·H·M·S Copeptin proAVP KRYPTOR
Learn moreProcalcitonin – A Tool for Managing Severe Infections in the Paediatric ICU
A large proportion of paediatric patients admitted to the PICU meets the SIRS Criteria even though a significant number do not have sepsis. However, it is difficult in the PICU to reliably distinguish SIRS patients who are infected versus those who are not. Clinical and laboratory signs are similar in both sets of patients. Procalcitonin (PCT) is a blood biomarker that can help discriminate between infectious and noninfectious causes of critical illness. PCT has been demonstrated to be the most useful tool for early identification of sepsis in the PICU, superior to other markers like CRP or leukocyte count.
Read more: Procalcitonin – A Tool for Managing Severe Infections in the Paediatric ICU
Biomarkers improving management in NEPC (Neuroendocrine prostate cancer)
International Workshop on Prostate Cancer Biomarkers
How to overcome antibiotic overuse in COVID-19 patients? Antibiotic stewardship programs with B·R·A·H·M·S PCT
Thermo Fisher Scientific invites you to join this online forum to learn more on the rule-out of bacterial coinfection in COVID-19 patients.
Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
Learn about the clinical properties of procalcitonin, and discover its benefits in diagnostics and antimicrobial stewardship.
Read more: Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
APAC Webinars on Prenatal Screening
The APAC Webinars on Prenatal Screening consist of a series of three lectures. A panel of acknowledged experts have been invited to provide lectures on prenatal screening including preeclampsia management throughout pregnancy.